168 related articles for article (PubMed ID: 31870961)
1. Novel Liposome Aggregate Platform (LAP) system for sustained retention of drugs in the posterior ocular segment following intravitreal injection.
Blazaki S; Pachis K; Tzatzarakis M; Tsilimbaris M; Antimisiaris SG
Int J Pharm; 2020 Feb; 576():118987. PubMed ID: 31870961
[TBL] [Abstract][Full Text] [Related]
2. Sustained release of intravitreal flurbiprofen from a novel drug-in-liposome-in-hydrogel formulation.
Pachis K; Blazaki S; Tzatzarakis M; Klepetsanis P; Naoumidi E; Tsilimbaris M; Antimisiaris SG
Eur J Pharm Sci; 2017 Nov; 109():324-333. PubMed ID: 28843864
[TBL] [Abstract][Full Text] [Related]
3. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.
El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF
Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and efficacy of intraocular flurbiprofen.
Blazaki S; Tsika C; Tzatzarakis M; Naoumidi E; Tsatsakis A; Tsatsanis C; Tsilimbaris MK
Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2375-2380. PubMed ID: 28963579
[TBL] [Abstract][Full Text] [Related]
5. Silk fibroin nanoparticles for enhanced bio-macromolecule delivery to the retina.
Yang P; Dong Y; Huang D; Zhu C; Liu H; Pan X; Wu C
Pharm Dev Technol; 2019 Jun; 24(5):575-583. PubMed ID: 30457420
[TBL] [Abstract][Full Text] [Related]
6. Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.
Kadam RS; Williams J; Tyagi P; Edelhauser HF; Kompella UB
Mol Vis; 2013; 19():1198-210. PubMed ID: 23734089
[TBL] [Abstract][Full Text] [Related]
7. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye.
Patel SR; Berezovsky DE; McCarey BE; Zarnitsyn V; Edelhauser HF; Prausnitz MR
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4433-41. PubMed ID: 22669719
[TBL] [Abstract][Full Text] [Related]
8. Drug-in-cyclodextrin-in-liposomes: A novel drug delivery system for flurbiprofen.
Zhang L; Zhang Q; Wang X; Zhang W; Lin C; Chen F; Yang X; Pan W
Int J Pharm; 2015 Aug; 492(1-2):40-5. PubMed ID: 26162980
[TBL] [Abstract][Full Text] [Related]
9. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation.
Prieto E; Cardiel MJ; Vispe E; Idoipe M; Garcia-Martin E; Fraile JM; Polo V; Mayoral JA; Pablo LE; Rodrigo MJ
Biomed Mater; 2020 Nov; 15(6):065021. PubMed ID: 32647098
[TBL] [Abstract][Full Text] [Related]
11. In vivo brain microdialysis to evaluate FITC-dextran encapsulated immunopegylated nanoparticles.
Bommana MM; Kirthivasan B; Squillante E
Drug Deliv; 2012 Aug; 19(6):298-306. PubMed ID: 22928708
[TBL] [Abstract][Full Text] [Related]
12. A novel oromucosal prolonged release mucoadhesive suspension by one step spray coagulation method.
Cilurzo F; Gennari CG; Selmin F; Musazzi UM; Rumio C; Minghetti P
Curr Drug Deliv; 2013 Jun; 10(3):251-60. PubMed ID: 23432365
[TBL] [Abstract][Full Text] [Related]
13. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
[TBL] [Abstract][Full Text] [Related]
14. [Ion-sensitive nanoemulsion-in situ gel system for ophthalmic delivery of flurbiprofen axetil].
Shen JQ; Gan Y; Gan L; Zhu CL; Zhu JB
Yao Xue Xue Bao; 2010 Jan; 45(1):120-5. PubMed ID: 21351461
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Nanocomposites Based on Liposomes and Layered Double Hydroxides Conjugated with Glycylsarcosine for Efficient Topical Drug Delivery to the Posterior Segment of the Eye.
Gu Y; Xu C; Wang Y; Zhou X; Fang L; Cao F
Mol Pharm; 2019 Jul; 16(7):2845-2857. PubMed ID: 31244219
[TBL] [Abstract][Full Text] [Related]
16. Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect.
Sonvico F; Conti C; Colombo G; Buttini F; Colombo P; Bettini R; Barchielli M; Leoni B; Loprete L; Rossi A
J Control Release; 2017 Sep; 262():296-304. PubMed ID: 28774840
[TBL] [Abstract][Full Text] [Related]
17. Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats.
Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Fattal E; Behar-Cohen F; de Kozak Y
Mol Vis; 2007 Dec; 13():2263-74. PubMed ID: 18451986
[TBL] [Abstract][Full Text] [Related]
18. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.
Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y
Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783
[TBL] [Abstract][Full Text] [Related]
19. The disposition of free and niosomally encapsulated Rac-flurbiprofen in dairy bovines.
Confalonieri EO; Soraci AL; Becaluba M; Denzoin L; Rodriguez E; Riccio B; Tapia O
J Vet Pharmacol Ther; 2010 Feb; 33(1):9-14. PubMed ID: 20444019
[TBL] [Abstract][Full Text] [Related]
20. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids.
Parmentier J; Becker MM; Heintz U; Fricker G
Int J Pharm; 2011 Feb; 405(1-2):210-7. PubMed ID: 21145956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
